Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 30/07/2024, to consider and approve unaudited consolidated and standalone financial results of the Company for the first quarter ended 30th June 2024.
The above information is a part of company’s filings submitted to BSE.